Health & Medicine
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
Following successful Phase 3 trial results, mRNA platforms are emerging as a versatile, rapid tool for training the immune system to target…
-
NHS rolls out first targeted anal cancer drug, extending survival to nearly three years
Retifanlimab plus chemotherapy adds 10 months of life for 250 patients annually in England, available immediately.
-
How the OncoMate MSI Dx Test Guides Pembrolizumab Therapy
Discover how the OncoMate MSI Dx test uses PCR technology to identify MSI-H solid tumors and match patients with pembrolizumab immunotherapy.
-
NIH Study Links Forever Chemicals to Aggressive Breast Cancer Rates
New research ties common synthetic chemicals to estrogen receptor-negative breast cancer, prompting fresh scrutiny on exposure risks.
Personal Finance
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
The IRS raises the elective deferral limit by $1,000 and expands catch-up contributions for workers 50 and older, creating new tax-deferral opportunities.
-
IRS Raises Annual Gift Exclusion to $20,000 for 2027, Enabling $320,000 Tax-Free Transfer for Couples
Inflation adjustment allows married couples to gift $40,000 per recipient annually without filing returns, accelerating estate reduction for high-net-worth families.
-
Divorcing One Month Early Can Cost $700 Monthly in Social Security for Life
The 10-year marriage rule for divorced spousal and survivor benefits creates a permanent financial cliff that many near the threshold overlook.
-
Medicare Part D Cap Rise to $2,400 Outweighs 2027 Ozempic Price Cuts
Patients relying on maintenance drugs like Ozempic face higher annual spending caps in 2027 despite new Medicare price negotiations.
Cancer News
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
Phase 1 data show 87% response and 18-month PFS; pivotal phase 2 met goals but BMS withheld numbers as phase 3 begins.
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
The FDA’s August 2026 approval of iberdomide introduces a new class of cancer drugs for patients with relapsed or refractory multiple myeloma.
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
WASHINGTON, July 7 — A 13-year gap between a mother’s breast cancer diagnosis and her daughter’s own diagnosis has laid bare persistent…
Health News
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
LONDON, July 15 — The shift is stark: a new study from the Indiana University School of Medicine suggests bowel cancer patients…
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
WASHINGTON — A new study suggests that drinking water with meals may trigger a psychological compensation mechanism, leading individuals to eat more.…
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
World News
-
The Black Sea Grain Initiative: A Deal That Collapsed in 2023
ISTANBUL, July 14 — The Black Sea Grain Initiative, a diplomatic arrangement that once allowed over 32 million metric tons of grain…
-
Kenyan families mark two years since 2024 protests with flowers, marches and calls for accountability
Nairobi, June 25 — As Kenya approaches the anniversary of the June 2024 protests, families of the victims are speaking out about…
-
Five Die After Car Hits Parked Truck on Hyderabad Outer Ring Road Near Adibatla
Pedda Amberpet Crash: Five Families Wait for Names as Road Safety Questions Mount Five families are waiting for official word. Police have…
-
Bus Overturns Into Gorge Near Chakri Interchange on Pakistan’s M2 Motorway, Killing 6
A devastating bus accident occurred on July 13, 2025, near the village of Chakri, Pakistan, resulting in the loss of six lives…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Dave Ramsey Assesses Retirement Viability for a 58-Year-Old With a $3 Million Nest Egg
-
Financial and Systemic Barriers Impede Early Bladder Cancer Care for Younger Veterans
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029